Last reviewed · How we verify
Alza Corporation, DE, USA — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
7 Phase 3
2 Phase 2
1 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| OROS® oxybutynin or Ditropan® | OROS® oxybutynin or Ditropan® | phase 3 | Anticholinergic agent | Muscarinic acetylcholine receptor (M3) | Urology / Neurology | |
| Ritalin (methylphenidate) | Ritalin (methylphenidate) | phase 3 | Central nervous system stimulant | Attention deficit hyperactivity disorder (ADHD) | ||
| OROS® oxybutynin | OROS® oxybutynin | phase 3 | Anticholinergic agent | Muscarinic acetylcholine receptors (M1-M5, primarily M3) | Urology / Gastroenterology | |
| OROS hydromorphone HCL ; OxyContin | OROS hydromorphone HCL ; OxyContin | phase 3 | opioid analgesic | opioid receptors | Pain management | |
| OROS Hydromorphone HCI | OROS Hydromorphone HCI | phase 3 | Opioid analgesic | Mu-opioid receptor (μ-OR) | Pain Management | |
| OROS hydromorphone HCL ; Morphine sulfate | OROS hydromorphone HCL ; Morphine sulfate | phase 3 | Opioid analgesic | Mu opioid receptor | Pain Management | |
| E-TRANS Fentanyl hydrochloride; Morphine | E-TRANS Fentanyl hydrochloride; Morphine | phase 3 | Opioid analgesic | Mu opioid receptor (μ-opioid receptor) | Pain Management |
Therapeutic area mix
- Pain Management · 3
- Attention deficit hyperactivity disorder (ADHD) · 1
- Pain management · 1
- Urology / Gastroenterology · 1
- Urology / Neurology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- · 2 shared drug classes
- GlaxoSmithKline · 2 shared drug classes
- Cephalon · 2 shared drug classes
- Ain Shams University · 1 shared drug class
- Archimedes Development Ltd · 1 shared drug class
- Asbjørn Mohr Drewes · 1 shared drug class
- Alexza Pharmaceuticals, Inc. · 1 shared drug class
- Assistance Publique Hopitaux De Marseille · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Alza Corporation, DE, USA:
- Alza Corporation, DE, USA pipeline updates — RSS
- Alza Corporation, DE, USA pipeline updates — Atom
- Alza Corporation, DE, USA pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Alza Corporation, DE, USA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alza-corporation-de-usa. Accessed 2026-05-17.